| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.98e-05 | 4 | 52 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | transporter activity | SEC61A2 ABCC3 ABCC1 ATP7A TMEM94 ATP10B CATSPER3 DISP1 SLC26A6 RYR1 RYR3 SLC4A2 | 9.18e-05 | 1289 | 52 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.91e-05 | 6 | 52 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.33e-04 | 758 | 52 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.74e-04 | 614 | 52 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.84e-04 | 8 | 52 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.86e-04 | 109 | 52 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SEC61A2 ABCC3 ABCC1 ATP7A TMEM94 CATSPER3 DISP1 SLC26A6 RYR1 RYR3 SLC4A2 | 1.88e-04 | 1180 | 52 | 11 | GO:0022857 |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.37e-04 | 9 | 52 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.95e-04 | 10 | 52 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 5.09e-04 | 13 | 52 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 5.09e-04 | 13 | 52 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.39e-04 | 61 | 52 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 6.83e-04 | 15 | 52 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 7.80e-04 | 16 | 52 | 2 | GO:0015562 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 9.91e-04 | 18 | 52 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.02e-03 | 171 | 52 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.18e-03 | 178 | 52 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.23e-03 | 20 | 52 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | protease binding | 1.26e-03 | 181 | 52 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.45e-03 | 477 | 52 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.67e-03 | 90 | 52 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.95e-03 | 31 | 52 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 3.14e-03 | 32 | 52 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 3.14e-03 | 32 | 52 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.34e-03 | 33 | 52 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.54e-03 | 34 | 52 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 3.78e-03 | 775 | 52 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.96e-03 | 36 | 52 | 2 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.96e-03 | 36 | 52 | 2 | GO:0015662 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.28e-03 | 793 | 52 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.62e-03 | 129 | 52 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 5.11e-03 | 41 | 52 | 2 | GO:0016877 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 5.81e-03 | 839 | 52 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 5.84e-03 | 840 | 52 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.84e-03 | 840 | 52 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.97e-03 | 279 | 52 | 4 | GO:0005096 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.40e-03 | 46 | 52 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 6.93e-03 | 656 | 52 | 6 | GO:0008047 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.07e-03 | 293 | 52 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.09e-03 | 465 | 52 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.15e-03 | 151 | 52 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 7.23e-03 | 49 | 52 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.77e-03 | 301 | 52 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.14e-02 | 62 | 52 | 2 | GO:0019829 | |
| GeneOntologyCellularComponent | basal part of cell | 3.97e-05 | 378 | 52 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.38e-04 | 320 | 52 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | junctional membrane complex | 2.16e-04 | 9 | 52 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.39e-04 | 354 | 52 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | calcium channel complex | 7.99e-04 | 73 | 52 | 3 | GO:0034704 | |
| MousePheno | impaired balance | 2.94e-05 | 121 | 42 | 5 | MP:0001525 | |
| MousePheno | fused cornea and lens | 4.89e-05 | 24 | 42 | 3 | MP:0001307 | |
| MousePheno | abnormal circulating mineral level | SEC61A2 ATP7A ARHGAP23 NAE1 DLG4 PRKDC AGAP7P AGAP4 AGAP6 CYRIB RYR1 | 1.10e-04 | 982 | 42 | 11 | MP:0006357 |
| MousePheno | absent pinna reflex | 1.43e-04 | 89 | 42 | 4 | MP:0006358 | |
| MousePheno | abnormal skin coloration | 2.04e-04 | 182 | 42 | 5 | MP:0011239 | |
| MousePheno | abnormal mineral level | SEC61A2 ATP7A ARHGAP23 NAE1 DLG4 PRKDC AGAP7P AGAP4 AGAP6 CYRIB RYR1 | 2.28e-04 | 1066 | 42 | 11 | MP:0000192 |
| MousePheno | abnormal pinna reflex | 2.33e-04 | 101 | 42 | 4 | MP:0001485 | |
| MousePheno | abnormal mineral homeostasis | SEC61A2 ATP7A ARHGAP23 NAE1 DLG4 PRKDC AGAP7P AGAP4 AGAP6 CYRIB RYR1 | 2.47e-04 | 1076 | 42 | 11 | MP:0005636 |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | SEC61A2 ACSL6 ABCC3 FLT1 PPP2R5C PSAP DLG4 AGAP7P SSTR5 AGAP4 AGAP6 RYR1 OTOG | 2.78e-04 | 1486 | 42 | 13 | MP:0002067 |
| MousePheno | abnormal tooth morphology | 3.48e-04 | 318 | 42 | 6 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 3.54e-04 | 319 | 42 | 6 | MP:0030254 | |
| Domain | Ryanrecept_TM4-6 | 2.19e-05 | 3 | 51 | 2 | IPR009460 | |
| Domain | RyR | 2.19e-05 | 3 | 51 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 2.19e-05 | 3 | 51 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 2.19e-05 | 3 | 51 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.19e-05 | 3 | 51 | 2 | IPR013333 | |
| Domain | Multidrug-R_assoc | 4.37e-05 | 4 | 51 | 2 | IPR005292 | |
| Domain | ArfGap | 6.67e-05 | 29 | 51 | 3 | SM00105 | |
| Domain | ArfGap | 6.67e-05 | 29 | 51 | 3 | PF01412 | |
| Domain | ARFGAP | 6.67e-05 | 29 | 51 | 3 | PS50115 | |
| Domain | ArfGAP | 6.67e-05 | 29 | 51 | 3 | IPR001164 | |
| Domain | FATC | 7.27e-05 | 5 | 51 | 2 | PF02260 | |
| Domain | RIH_assoc | 1.09e-04 | 6 | 51 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.09e-04 | 6 | 51 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.09e-04 | 6 | 51 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.09e-04 | 6 | 51 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.09e-04 | 6 | 51 | 2 | IPR015925 | |
| Domain | FAT | 1.09e-04 | 6 | 51 | 2 | PS51189 | |
| Domain | FATC | 1.09e-04 | 6 | 51 | 2 | PS51190 | |
| Domain | - | 1.09e-04 | 6 | 51 | 2 | 1.25.10.30 | |
| Domain | FATC_dom | 1.09e-04 | 6 | 51 | 2 | IPR003152 | |
| Domain | RYDR_ITPR | 1.09e-04 | 6 | 51 | 2 | PF01365 | |
| Domain | PIK_FAT | 1.09e-04 | 6 | 51 | 2 | IPR014009 | |
| Domain | Ins145_P3_rec | 1.09e-04 | 6 | 51 | 2 | PF08709 | |
| Domain | FATC | 1.09e-04 | 6 | 51 | 2 | SM01343 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.40e-04 | 37 | 51 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.40e-04 | 37 | 51 | 3 | PF00122 | |
| Domain | ARM-type_fold | 3.10e-04 | 339 | 51 | 6 | IPR016024 | |
| Domain | MIR | 3.24e-04 | 10 | 51 | 2 | PS50919 | |
| Domain | MIR | 3.24e-04 | 10 | 51 | 2 | PF02815 | |
| Domain | MIR | 3.24e-04 | 10 | 51 | 2 | SM00472 | |
| Domain | MIR_motif | 3.24e-04 | 10 | 51 | 2 | IPR016093 | |
| Domain | PI3/4_kinase_CS | 7.50e-04 | 15 | 51 | 2 | IPR018936 | |
| Domain | ARM-like | 8.30e-04 | 270 | 51 | 5 | IPR011989 | |
| Domain | - | 8.56e-04 | 16 | 51 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 8.56e-04 | 16 | 51 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 1.09e-03 | 18 | 51 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.09e-03 | 18 | 51 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.09e-03 | 18 | 51 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.09e-03 | 18 | 51 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.09e-03 | 18 | 51 | 2 | PS00916 | |
| Domain | ABC_membrane | 1.94e-03 | 24 | 51 | 2 | PF00664 | |
| Domain | ABC_TM1F | 2.64e-03 | 28 | 51 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 2.64e-03 | 28 | 51 | 2 | IPR011527 | |
| Domain | - | 3.14e-03 | 222 | 51 | 4 | 1.25.10.10 | |
| Domain | - | 3.44e-03 | 32 | 51 | 2 | 3.40.1110.10 | |
| Domain | - | 3.44e-03 | 32 | 51 | 2 | 2.70.150.10 | |
| Domain | Ion_trans_dom | 3.73e-03 | 114 | 51 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.73e-03 | 114 | 51 | 3 | PF00520 | |
| Domain | ATPase_P-typ_cyto_domN | 4.11e-03 | 35 | 51 | 2 | IPR023299 | |
| Domain | P_typ_ATPase | 4.34e-03 | 36 | 51 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.34e-03 | 36 | 51 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.34e-03 | 36 | 51 | 2 | PS00154 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 8.21e-05 | 5 | 41 | 2 | MM1586 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.18e-04 | 681 | 41 | 9 | MM14985 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.23e-04 | 6 | 41 | 2 | M22078 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.13e-04 | 736 | 41 | 9 | M27287 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 2.29e-04 | 8 | 41 | 2 | M48022 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47958 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 2.63e-07 | 9 | 52 | 3 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 3.75e-07 | 10 | 52 | 3 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 5.16e-07 | 11 | 52 | 3 | 15381706 | |
| Pubmed | 8.92e-07 | 13 | 52 | 3 | 27713690 | ||
| Pubmed | 1.13e-06 | 14 | 52 | 3 | 22453919 | ||
| Pubmed | 1.14e-06 | 529 | 52 | 8 | 14621295 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 12565913 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9489997 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9192302 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 2.19e-06 | 2 | 52 | 2 | 12640042 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 7556644 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 14592949 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28377452 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 2.19e-06 | 2 | 52 | 2 | 15894801 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9799464 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9817784 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.19e-06 | 2 | 52 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 2.19e-06 | 2 | 52 | 2 | 11500519 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 27739315 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18403125 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 11171121 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 11820781 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18313230 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 27655403 | ||
| Pubmed | The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. | 6.57e-06 | 3 | 52 | 2 | 12628490 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18434746 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18799096 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 6.57e-06 | 3 | 52 | 2 | 9204703 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 7876312 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 21881589 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 17845218 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 6.57e-06 | 3 | 52 | 2 | 12213830 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 9242641 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 15886284 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 6.57e-06 | 3 | 52 | 2 | 10788707 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 21799180 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 6.57e-06 | 3 | 52 | 2 | 7621815 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18643873 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 11159936 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 17494643 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 6.57e-06 | 3 | 52 | 2 | 10473538 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 6.57e-06 | 3 | 52 | 2 | 4600883 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 7635066 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.10e-05 | 195 | 52 | 5 | 17110338 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 22100703 | ||
| Pubmed | Identification of an apical Cl(-)/HCO3(-) exchanger in the small intestine. | 1.31e-05 | 4 | 52 | 2 | 11842009 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 18206662 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 18038766 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.31e-05 | 4 | 52 | 2 | 23413940 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 9384575 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 9607712 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 16946557 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 23482488 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 23918386 | ||
| Pubmed | Efflux protein expression in human stem cell-derived retinal pigment epithelial cells. | 2.19e-05 | 5 | 52 | 2 | 22272278 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 21596751 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 2.19e-05 | 5 | 52 | 2 | 19011160 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.28e-05 | 6 | 52 | 2 | 26025922 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 23463619 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 10444070 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.28e-05 | 6 | 52 | 2 | 14592808 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.28e-05 | 6 | 52 | 2 | 25966694 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.28e-05 | 6 | 52 | 2 | 16844763 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 12951053 | ||
| Pubmed | 4.34e-05 | 430 | 52 | 6 | 32581705 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 11860456 | ||
| Pubmed | Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. | 4.58e-05 | 7 | 52 | 2 | 20922799 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 20962236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 6.10e-05 | 8 | 52 | 2 | 19033399 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 20810650 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 21441923 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 15802388 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 6.10e-05 | 8 | 52 | 2 | 30563862 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 11784029 | ||
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 21858002 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 9.79e-05 | 10 | 52 | 2 | 18160036 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.20e-04 | 11 | 52 | 2 | 20427287 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.27e-04 | 171 | 52 | 4 | 20201926 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 19095005 | ||
| Pubmed | Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. | 1.43e-04 | 12 | 52 | 2 | 16541024 | |
| Pubmed | Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia. | 1.61e-04 | 70 | 52 | 3 | 35008187 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.01e-04 | 569 | 52 | 6 | 30639242 | |
| Pubmed | The ubiquitin specific protease-4 (USP4) interacts with the S9/Rpn6 subunit of the proteasome. | 2.60e-04 | 16 | 52 | 2 | 23022198 | |
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 10428027 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 3.21e-04 | 218 | 52 | 4 | 33378226 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 3.60e-04 | 92 | 52 | 3 | 10493829 | |
| Pubmed | 5.93e-04 | 24 | 52 | 2 | 34983926 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 6.93e-04 | 719 | 52 | 6 | 35337019 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 6.96e-04 | 26 | 52 | 2 | 34848499 | |
| Pubmed | 7.67e-04 | 733 | 52 | 6 | 34672954 | ||
| Pubmed | Developmental gene expression profiling along the tonotopic axis of the mouse cochlea. | 8.08e-04 | 28 | 52 | 2 | 22808246 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.32e-04 | 281 | 52 | 4 | 28706196 | |
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 20371770 | ||
| Pubmed | Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. | 8.67e-04 | 29 | 52 | 2 | 12652657 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.36e-05 | 3 | 39 | 2 | 287 | |
| GeneFamily | ArfGAPs | 4.84e-05 | 33 | 39 | 3 | 395 | |
| GeneFamily | ATP binding cassette subfamily C | 3.48e-04 | 13 | 39 | 2 | 807 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 6.04e-04 | 17 | 39 | 2 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.85e-04 | 206 | 39 | 4 | 682 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.76e-06 | 44 | 52 | 4 | MM485 | |
| ToppCell | Caecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype | 3.45e-06 | 198 | 52 | 5 | 64278d8831c81874937e76b561c53928dfc437c5 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass | 3.45e-06 | 198 | 52 | 5 | 5b719b67f8384863077070e1eb7e04a320e6dab4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-05 | 140 | 52 | 4 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.07e-05 | 153 | 52 | 4 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.31e-05 | 156 | 52 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.52e-05 | 169 | 52 | 4 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 4.62e-05 | 170 | 52 | 4 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 5.65e-05 | 179 | 52 | 4 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.90e-05 | 181 | 52 | 4 | 9bfd93cf053beaee806cacdffd7abef02f94aec6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.29e-05 | 184 | 52 | 4 | 2c2125b8030af83f7a6d59a7102d4de8e0ac1988 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.42e-05 | 185 | 52 | 4 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | Control-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 6.42e-05 | 185 | 52 | 4 | d5d6d13e2f20b54ca55645b9a757b8599f4fd897 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-05 | 187 | 52 | 4 | 0ef82111b9049cc7ee78d64d240e1f10ab14d6b6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-05 | 187 | 52 | 4 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 188 | 52 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 188 | 52 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 6.83e-05 | 188 | 52 | 4 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-05 | 189 | 52 | 4 | 9e58411e51019ca59e78d3e737d65d2bcbbea2be | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 190 | 52 | 4 | 9a2244c3973aee7270646bf00db7727edb9decc5 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 7.12e-05 | 190 | 52 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 192 | 52 | 4 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-05 | 197 | 52 | 4 | 98e34e8612f111bb667a574de1faaa785d318ca4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-05 | 199 | 52 | 4 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.51e-05 | 199 | 52 | 4 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.68e-05 | 200 | 52 | 4 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 5ab588808c1fc384019413401ab4bf9bc06bf529 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.68e-05 | 200 | 52 | 4 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.68e-05 | 200 | 52 | 4 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.68e-05 | 200 | 52 | 4 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Opalin_(Opalin)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 82 | 52 | 3 | 5cd8e47edb775eabf3e9a407c1c2d8a78afb9509 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 82 | 52 | 3 | 1eeb259ec555879ee1962b7bc2c31c200fbb85cf | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.29e-04 | 126 | 52 | 3 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.13e-04 | 134 | 52 | 3 | a632d78890fcc20db81d2cf6b299470706d2e182 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.13e-04 | 134 | 52 | 3 | 8be2db71d9d29f9a57a64efdc89cf8c3e32b363b | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.13e-04 | 134 | 52 | 3 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.36e-04 | 136 | 52 | 3 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | MS-CD4-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 5.95e-04 | 141 | 52 | 3 | df257dd4dcc45c1ace57340798e150a6e932531d | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.45e-04 | 145 | 52 | 3 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-04 | 147 | 52 | 3 | 22c9605869dd2e789896cd2790ee8def2605de57 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-04 | 147 | 52 | 3 | ac272595818d25c6b84b107555b3351e912a01a7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-04 | 148 | 52 | 3 | 3f48f5ba0a0928ddf6da7a1be1976933921f42ad | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-04 | 151 | 52 | 3 | 79827a76c675dcb82f59c0a45d0f962b02d5bfd6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-04 | 152 | 52 | 3 | b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.40e-04 | 152 | 52 | 3 | 669d8f12fdb110ed72f4e5348b7b5350144a061c | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 7.54e-04 | 153 | 52 | 3 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.69e-04 | 154 | 52 | 3 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.83e-04 | 155 | 52 | 3 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.98e-04 | 156 | 52 | 3 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.13e-04 | 157 | 52 | 3 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 157 | 52 | 3 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 367C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 157 | 52 | 3 | f511871e1a004c6e9af08ee325ab1bfc41807487 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 157 | 52 | 3 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.13e-04 | 157 | 52 | 3 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.13e-04 | 157 | 52 | 3 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | 718eafcf8a171bb69b402dc9d69564c3521a62a9 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 158 | 52 | 3 | c8df636412a08c570f235c34d4cff46924a9b11d | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 8.43e-04 | 159 | 52 | 3 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 8.74e-04 | 161 | 52 | 3 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.90e-04 | 162 | 52 | 3 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.06e-04 | 163 | 52 | 3 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-04 | 163 | 52 | 3 | 2dbdcbc4c187aad3db837d191cc78662a75dd0b5 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-04 | 163 | 52 | 3 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 9.06e-04 | 163 | 52 | 3 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.22e-04 | 164 | 52 | 3 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.38e-04 | 165 | 52 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.38e-04 | 165 | 52 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.38e-04 | 165 | 52 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.55e-04 | 166 | 52 | 3 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 9.71e-04 | 167 | 52 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.88e-04 | 168 | 52 | 3 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-03 | 169 | 52 | 3 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | ASK428-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-03 | 41 | 52 | 2 | a72d926de3dc9e420b80764af88002e436517790 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 172 | 52 | 3 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 172 | 52 | 3 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-03 | 172 | 52 | 3 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.06e-03 | 172 | 52 | 3 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-03 | 172 | 52 | 3 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-03 | 173 | 52 | 3 | 3877cead288ce9509e6cccf57e55ec5e1bd7ce18 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-03 | 174 | 52 | 3 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-03 | 175 | 52 | 3 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-03 | 176 | 52 | 3 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-03 | 176 | 52 | 3 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-03 | 176 | 52 | 3 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-03 | 177 | 52 | 3 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-03 | 177 | 52 | 3 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.17e-03 | 178 | 52 | 3 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.17e-03 | 178 | 52 | 3 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 178 | 52 | 3 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 178 | 52 | 3 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 178 | 52 | 3 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 178 | 52 | 3 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-mo-Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.19e-03 | 179 | 52 | 3 | cd3c58e044f5a38e815313a1636153d81a592fce | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-03 | 179 | 52 | 3 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.19e-03 | 179 | 52 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| Drug | Kn 04 | 3.48e-07 | 26 | 52 | 4 | CID000131117 | |
| Drug | CHEBI:564108 | 3.91e-07 | 7 | 52 | 3 | CID006400637 | |
| Drug | lactosyl lysosphingolipid | 9.35e-07 | 9 | 52 | 3 | CID006439268 | |
| Drug | platinum | 3.72e-06 | 183 | 52 | 6 | CID000023939 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 5.12e-06 | 2 | 52 | 2 | ctd:C005147 | |
| Drug | Apa-sg | 1.06e-05 | 19 | 52 | 3 | CID000126348 | |
| Drug | 2-hydroxycarbazole | 1.53e-05 | 3 | 52 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.53e-05 | 3 | 52 | 2 | CID000080262 | |
| Drug | cis-diammineplatinum(II | 1.53e-05 | 3 | 52 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.53e-05 | 3 | 52 | 2 | CID002750949 | |
| Drug | flubendiamide | 1.53e-05 | 3 | 52 | 2 | CID011193251 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.53e-05 | 3 | 52 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 1.53e-05 | 3 | 52 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.53e-05 | 3 | 52 | 2 | CID009570289 | |
| Drug | 5-carboxyfluorescein diacetate | 1.53e-05 | 3 | 52 | 2 | ctd:C084577 | |
| Drug | A-30 | 3.06e-05 | 4 | 52 | 2 | CID003028528 | |
| Drug | PCB74 | 3.06e-05 | 4 | 52 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 3.06e-05 | 4 | 52 | 2 | CID006444275 | |
| Drug | Bastadin 10 | 3.06e-05 | 4 | 52 | 2 | CID009589366 | |
| Drug | SC 38249 | 3.06e-05 | 4 | 52 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 3.06e-05 | 4 | 52 | 2 | CID000035682 | |
| Drug | grepafloxacin glucuronide | 3.06e-05 | 4 | 52 | 2 | CID000443296 | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.19e-05 | 177 | 52 | 5 | 4164_UP | |
| Drug | prinomastat | 5.84e-05 | 33 | 52 | 3 | CID000466151 | |
| Drug | H2DIDS | 5.84e-05 | 33 | 52 | 3 | CID000115184 | |
| Drug | ruthenium | 6.34e-05 | 94 | 52 | 4 | CID000023950 | |
| Drug | AC1LAHTK | 7.63e-05 | 6 | 52 | 2 | CID000468713 | |
| Drug | AC1NB6SN | 7.63e-05 | 6 | 52 | 2 | CID004488324 | |
| Drug | MBED | 7.63e-05 | 6 | 52 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 7.63e-05 | 6 | 52 | 2 | CID000012008 | |
| Drug | AC1O528X | 7.63e-05 | 6 | 52 | 2 | CID006475857 | |
| Drug | NSC114784 | 7.63e-05 | 6 | 52 | 2 | CID000419425 | |
| Drug | NSC692750 | 7.63e-05 | 6 | 52 | 2 | CID000078910 | |
| Drug | Azumoleno | 1.07e-04 | 7 | 52 | 2 | CID000056259 | |
| Drug | mag-indo-1 | 1.07e-04 | 7 | 52 | 2 | CID000131881 | |
| Drug | Br2BAPTA | 1.07e-04 | 7 | 52 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.07e-04 | 7 | 52 | 2 | CID009547999 | |
| Drug | calcein AM | 1.42e-04 | 8 | 52 | 2 | ctd:C085925 | |
| Drug | nicotine glucuronide | 1.42e-04 | 8 | 52 | 2 | CID003035848 | |
| Drug | lanreotide | 1.42e-04 | 8 | 52 | 2 | ctd:C060347 | |
| Drug | 4,4'-dithiodipyridine | 1.49e-04 | 45 | 52 | 3 | CID000075846 | |
| Drug | axitinib | 1.49e-04 | 45 | 52 | 3 | CID006450551 | |
| Drug | fluo-3 | 1.74e-04 | 122 | 52 | 4 | CID000104978 | |
| Drug | 1,3,5-triethylbenzene | 1.82e-04 | 9 | 52 | 2 | CID000007602 | |
| Drug | FLA 365 | 1.82e-04 | 9 | 52 | 2 | CID000072776 | |
| Drug | etridiazole | 2.04e-04 | 50 | 52 | 3 | CID000017432 | |
| Drug | 1y2g | 2.16e-04 | 129 | 52 | 4 | CID005287936 | |
| Drug | mercury | 2.20e-04 | 542 | 52 | 7 | CID000023931 | |
| Drug | arpromidine | 2.28e-04 | 10 | 52 | 2 | CID000065895 | |
| Drug | AC1N38XE | 2.28e-04 | 10 | 52 | 2 | CID004060965 | |
| Drug | AC1NN9F1 | 2.28e-04 | 10 | 52 | 2 | CID000000410 | |
| Drug | PCB 95 | 2.28e-04 | 10 | 52 | 2 | CID000038012 | |
| Drug | AC1L1IZE | 2.29e-04 | 131 | 52 | 4 | CID000004799 | |
| Drug | CsCl | 2.64e-04 | 136 | 52 | 4 | CID000024293 | |
| Drug | PCB 66 | 2.78e-04 | 11 | 52 | 2 | CID000036185 | |
| Drug | R 478 | 2.78e-04 | 11 | 52 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 2.78e-04 | 11 | 52 | 2 | CID003081323 | |
| Drug | BAPNA | 3.01e-04 | 57 | 52 | 3 | CID000013494 | |
| Drug | Ryanodine | 3.33e-04 | 12 | 52 | 2 | ctd:D012433 | |
| Disease | cerebral palsy (implicated_via_orthology) | 6.14e-07 | 10 | 52 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 9.13e-06 | 3 | 52 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 9.13e-06 | 3 | 52 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Papillary Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.51e-03 | 128 | 52 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.51e-03 | 128 | 52 | 3 | C1266044 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLTMTIISVTLEIPH | 136 | Q96P64 | |
| PIAILIMVLVDYSIE | 941 | P04920 | |
| YEIVHVLSLMLEDLP | 371 | Q86XQ3 | |
| VVATMPDLYHLLVEL | 126 | Q8WYA6 | |
| VITEPIYPEVVHMFA | 86 | Q13362 | |
| LMDTVYPAIAIVIVL | 501 | Q96F81 | |
| EVFHREITMLPLAIV | 111 | O94823 | |
| YMVLVPSLLHTETTE | 31 | P01023 | |
| LMHLLEEPIYLSAVV | 316 | Q9BUB4 | |
| YLTMTIISVTLEIPH | 136 | Q5VW22 | |
| ATIVYQPHLISVEEM | 211 | Q04656 | |
| IYVVDEVLAPVILML | 1076 | O15438 | |
| VQYLDEPMLTVHQTV | 126 | Q8NFP4 | |
| IEKHTMVIEYIGTII | 4791 | Q8NEZ4 | |
| YAVPVTVMEPHTESL | 1646 | Q14999 | |
| PYVHLVSITVMVILF | 106 | Q6W3E5 | |
| EIYVIEDNTVTIPLM | 1106 | P17301 | |
| VDVVMLIFVLSAVHP | 151 | Q8TCB7 | |
| ILVIITDTQLHTPMY | 46 | P47890 | |
| AHFTEPLVEATIMVY | 2406 | Q9P2D7 | |
| YLTMTIISVTLEIPH | 136 | Q5VUJ5 | |
| VTQMEVHYARPIIIL | 526 | P78352 | |
| VIHLMLPETREIYEL | 176 | Q96EH3 | |
| LHMVTEYNPVTVIGL | 141 | Q96DN0 | |
| VMVGVIILYDHVHPV | 256 | Q9NUQ9 | |
| EIYDIISMVSVIHIP | 186 | Q99675 | |
| ISMVSVIHIPDRTYK | 191 | Q99675 | |
| YPEHVCEVLLTMERT | 541 | Q15020 | |
| ARYTEMPHVIEITLP | 3261 | P21817 | |
| IVIVSLDQSLHVPMY | 46 | Q8NH74 | |
| YILSQSPDEMLTVHV | 2136 | Q6ZRI0 | |
| THSMSYLPQVDVIIV | 826 | P33527 | |
| VVIRQVYHLMETTPT | 641 | Q96DN5 | |
| EDPVHVVVYIIFMLG | 356 | Q9H9S3 | |
| LLLVVVRTQMPHYSV | 501 | Q9BXS9 | |
| HVIIPLLHTVMYVLT | 71 | Q5UE93 | |
| VLIDMTTGEVVHIDY | 2341 | Q96Q15 | |
| TVMSVDRYLAVVHPL | 131 | P35346 | |
| MPYTDVVIHEIQRLV | 1 | Q6ZSU1 | |
| PLAHMFERVIQSVVY | 321 | Q9UKU0 | |
| VVLPTYDITHSMLEA | 271 | Q7Z4H8 | |
| LEDLLIEHPSMSVYV | 96 | Q8IXH6 | |
| VQSVMLHYAVPVVLA | 276 | Q12767 | |
| GARYTEMPHVIEVIL | 3121 | Q15413 | |
| YPVECLALTVEEVMH | 551 | Q08AE8 | |
| VTHMPDRYKIVETLI | 1076 | Q9P227 | |
| AEYEPVLIEILVEVM | 456 | P07602 | |
| ILTYFPVVHPVMIAV | 56 | O95859 | |
| YTPVLEHLVVMQIDS | 431 | P78527 | |
| GIHYMVVEIVATILS | 2181 | P78527 | |
| IITEEMPLLEVFFIH | 906 | Q9Y2L5 | |
| VMLETYNHLVSLEIP | 61 | P10072 | |
| VEMYSEIPEIIHMTE | 136 | P17948 | |
| YMRIIIKEHPVIESH | 161 | Q13564 |